{"id":62106,"date":"2025-10-29T04:07:14","date_gmt":"2025-10-29T03:07:14","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/medtech-innovator-asia-pacific-names-australis-scientific-top-innovator-in-2025-grand-finals-competition\/"},"modified":"2025-10-29T04:07:14","modified_gmt":"2025-10-29T03:07:14","slug":"medtech-innovator-asia-pacific-names-australis-scientific-top-innovator-in-2025-grand-finals-competition","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/medtech-innovator-asia-pacific-names-australis-scientific-top-innovator-in-2025-grand-finals-competition\/","title":{"rendered":"MedTech Innovator Asia Pacific Names Australis Scientific Top Innovator in 2025 Grand Finals Competition"},"content":{"rendered":"
\n

\nMedical device company developing smart patch delivering minimally invasive neuromodulation therapy for overactive bladder, is awarded Grand Prize of USD 175,000 at the 7th annual grand finals event<\/i><\/p>\n

LOS ANGELES & SINGAPORE–(BUSINESS WIRE)–MedTech Innovator (MTI)<\/a>, the world\u2019s largest and most impactful accelerator for medical technology startups, today announced that Australis Scientific<\/a> has been named the 2025 MedTech Innovator Asia Pacific Grand Prize Winner, receiving USD 175,000 in non-dilutive funding for their innovative smart patch delivering minimally invasive neuromodulation therapy for overactive bladder. The other finalists\u2014F.MED<\/a>, HemoTag<\/a>, OsseoLabs<\/a>\u2014each received USD 10,000 as runner-up prizes.<\/p>\n

<\/a>
<\/a>
<\/a>
<\/a><\/p>\n

\n\u201cWe\u2019re honored to have been named the 2025 MedTech Innovator APAC Grand Prize Winner,\u201d said Nicky Agahari, co-founder and CEO, Australis Scientific. \u201cMore than the recognition, what we value most is the community we\u2019ve gained including the MTI team, our fellow founders, and our strategic mentors at BD who have shared their experience and support so generously. This journey reminds us that when we work together, we can bring forward medical technologies that truly change lives.\u201d<\/p>\n

\nThe 2025 Grand Finals marked the first year MedTech Innovator Asia Pacific hosted the event independently in Singapore, underscoring the accelerator\u2019s growth and maturity as the region\u2019s leading platform for advancing medtech innovation.<\/p>\n

\n\u201cWe\u2019re thrilled to recognize Australis Scientific as our 2025 Asia Pacific Grand Prize Winner among a field of truly outstanding companies in this year\u2019s finals,\u201d said Paul Grand, founder and CEO of MedTech Innovator. \u201cAustralis Scientific\u2019s smart patch for overactive bladder has the potential to make a significant impact by improving millions of lives. They reflect the innovation and momentum we\u2019re seeing across APAC, with breakthrough solutions that are less invasive, more accessible, and designed for global adoption.\u201d<\/p>\n

\nFollowing each finalist\u2019s presentation, a panel of distinguished medtech executives engaged in a Q&A session with the finalists, with the winner determined by a live audience vote. The panel included Roger Da, associate director of New Business Development, China, Johnson & Johnson MedTech; Dr. Fu Yongji, vice president, head of R&D, B. Braun Medical; Eric Liu, vice president of R&D, Greater Asia, Becton Dickinson.<\/p>\n

\nIn addition to the Grand Prize and runner-up awards, several additional honors were presented to recognize outstanding achievements among this year\u2019s cohort of innovators:<\/p>\n